会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明授权
    • Chemical control over ceramic porosity using carboxylate-alumoxanes
    • 使用羧酸盐 - 铝氧烷化学控制陶瓷孔隙率
    • US06936306B1
    • 2005-08-30
    • US09670230
    • 2000-09-28
    • Andrew R. BarronDiane Amy BaileyMark Robert WiesnerChristopher Daniel JonesRhonda Lynn Callender
    • Andrew R. BarronDiane Amy BaileyMark Robert WiesnerChristopher Daniel JonesRhonda Lynn Callender
    • B01D67/00B01D71/02B05D3/02C03C17/00C04B35/628C04B38/00
    • B01D67/0039B01D67/0041B01D67/0076B01D71/025B01D2323/08B01D2323/24C03C17/007C03C2217/425C04B35/62852C04B35/62886C04B38/0074C04B2235/3208C04B2235/3225C04B2235/5224C04B2235/5244C04B2235/5248C04B2235/6562C04B35/101C04B38/0051
    • This invention relates generally to a method for controlling the pore size, pore size distribution and porosity of aluminum-oxide based ceramics through the choice of substituents on carboxylate-alumoxanes and aluminum-oxide nanoparticles. The method allows for the formation of intra-granular pores in the nanometer range to be created in alumina and aluminum oxide ceramic bodies. The control over pore size and pore size distribution is accomplished through the use of different chemical substituents on the carboxylate-alumoxanes and aluminum-oxide nanoparticles. The size and distribution of pores within the alumina-oxide ceramic are dependent on the identity of the carboxylate substituents. In particular the formation of intra-versus inter-granular porosity is dependent on the identity of the carboxylate substituents. The invention also provides methods for the manufacture of ceramic coatings on ceramic and carbon fibers for composite applications and ceramic membranes with nanometer sized pores. The pore size, pore size distribution and porosity, and hence the strength, permeability and surface adhesion, of the ceramic coating is controlled by the choice of substituent on the carboxylate-alumoxane. Thermolysis of self supporting spun layers of the carboxylate-alumoxanes results in disks of alumina with controlled pore size, pore size distribution and porosity. In an alternative method a porous substrate is dipped or coated with a solution of the carboxylate-alumoxane, followed by thermolysis to produce a composite membrane.
    • 本发明一般涉及通过选择羧酸盐 - 铝氧烷和氧化铝纳米颗粒上的取代基来控制氧化铝基陶瓷的孔径,孔径分布和孔隙率的方法。 该方法允许在氧化铝和氧化铝陶瓷体中形成纳米范围内的颗粒内孔。 通过在羧酸盐 - 铝氧烷和氧化铝纳米颗粒上使用不同的化学取代基来实现孔径和孔径分布的控制。 氧化铝 - 氧化物陶瓷内的孔的大小和分布取决于羧酸盐取代基的同一性。 特别地,孔内和颗粒间孔隙度的形成取决于羧酸盐取代基的同一性。 本发明还提供了用于复合应用的陶瓷和碳纤维上的陶瓷涂层的制造方法以及具有纳米尺寸孔的陶瓷膜。 陶瓷涂层的孔径,孔径分布和孔隙率以及强度,渗透性和表面粘附性由羧酸铝 - 铝氧烷上的取代基的选择来控制。 羧酸铝铝氧烷的自支撑纺丝层的热解产生具有可控孔径,孔径分布和孔隙率的氧化铝盘。 在另一种方法中,多孔基材浸渍或涂覆有羧酸盐 - 铝氧烷的溶液,然后进行热分解以产生复合膜。
    • 54. 发明申请
    • TUNING BIOLOGICAL SYSTEM PROPERTIES FOR OPTIMIZED TREATMENT EFFICACY
    • 调节生物系统性能优化治疗效果
    • US20160263150A1
    • 2016-09-15
    • US15067010
    • 2016-03-10
    • Nadia C. LaraAndrew R. BarronStuart CorrSteven Curley
    • Nadia C. LaraAndrew R. BarronStuart CorrSteven Curley
    • A61K33/00
    • A61K33/44A61K9/14A61K33/10A61K33/24
    • Various embodiments of the present disclosure pertain to methods of optimizing a treatment efficacy of a biological system by tuning a property of the biological system through the addition of an optimizing agent to the biological system. The tuning can include: (a) determining a property parameter of the biological system; (b) selecting an optimizing agent to be added to the biological system based on the determined property parameter; and (c) adding the optimizing agent to the biological system. The optimizing agent can include a kosmotropic material. The biological system can include a tissue, such as a tumor. The methods of the present disclosure can be utilized to enhance the efficacy of various treatments, such as the heat treatment of a biological system exposed to a radiofrequency field. The methods of the present disclosure can also include a step of treating the biological system.
    • 本公开的各种实施方案涉及通过通过向生物系统添加优化剂来调节生物系统的性质来优化生物系统的治疗功效的方法。 调整可以包括:(a)确定生物系统的属性参数; (b)基于所确定的属性参数选择要添加到所述生物系统的优化剂; 和(c)将优化剂加入到生物系统中。 优化剂可以包括一种感光性材料。 生物系统可以包括诸如肿瘤的组织。 本公开的方法可以用于增强各种治疗的功效,例如暴露于射频场的生物系统的热处理。 本公开的方法还可以包括处理生物系统的步骤。
    • 56. 发明授权
    • Analyzing the transport of plasmonic particles through mineral formations
    • 通过矿物地层分析等离子体激元粒子的运输
    • US08575548B2
    • 2013-11-05
    • US13701769
    • 2011-06-02
    • Andrew R. BarronSamuel J. Maguire-BoyleAlvin White Orbaek
    • Andrew R. BarronSamuel J. Maguire-BoyleAlvin White Orbaek
    • H01J37/05H01J37/28G01N33/62
    • G01V8/02G01N30/74G01N33/24G01N2015/0693G01N2021/258
    • A transport of plasmonic particles through a mineral formation is analyzed by flowing a plasmonic particles solution through an immobile phase (e.g., a mineral formation), determining an absorbance of the plasmonic particles solution subsequent to flowing the plasmonic particles solution through the immobile phase, comparing the determined absorbance of the plasmonic particles solution with an absorbance of the plasmonic particles solution determined previous to flowing the plasmonic particles solution through the immobile phase, and determining an absorbance of the plasmonic particles to the immobile phase as a function of the comparison. The plasmonic particles solution may be produced by dissolving or suspending plasmonic particles in a mobile phase. Flowing the plasmonic particles solution through the immobile phase may include injecting the plasmonic particles solution into the immobile phase, and then flushing the plasmonic particles solution through the immobile phase.
    • 通过使等离子体颗粒溶液流过固定相(例如矿物形成)来分析通过矿物形成的等离子体激元粒子的运输,确定等离子体激元粒子溶液在使等离子体激元粒子溶液流过固定相后的吸光度,比较 所述等离子体激元粒子溶液的吸光度与先前将等离子体激元粒子溶液流过固定相所确定的等离子体激元粒子溶液的吸光度,以及根据比较确定等离子体激元粒子与固定相的吸光度。 等离子体颗粒溶液可以通过将等离子体激元粒子溶解或悬浮在流动相中来制备。 将等离子体激元颗粒溶液流过固定相可包括将等离子体激元颗粒溶液注入固定相,然后通过固定相冲洗等离子体颗粒溶液。